Allogeneic hematopoietic cell transplantation in the management of GATA2 deficiency and pulmonary alveolar proteinosis.

van Lier, Yannouck F; de Bree, Godelieve J; Jonkers, René E; Roelofs, Joris J T H; Ten Berge, Ineke J M; Rutten, Caroline E; Nur, Erfan; Kuijpers, Taco W; Hazenberg, Mette D; Zeerleder, Sacha S. (2020). Allogeneic hematopoietic cell transplantation in the management of GATA2 deficiency and pulmonary alveolar proteinosis. Clinical immunology, 218(108522), p. 108522. Elsevier 10.1016/j.clim.2020.108522

Text Allogeneic hematopoietic.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (1MB) | Request a copy

Human hematopoiesis is critically dependent on the transcription factor GATA2. Patients with GATA2 deficiency typically present with myelodysplastic syndrome, reduced numbers of monocytes, NK cells and B cells, and/or opportunistic infections. Here, we present two families that harbor distinct GATA2 mutations with highly variable onset and course of disease. We discuss the use of allogeneic hematopoietic cell transplantation in these patients, especially as treatment for pulmonary alveolar proteinosis.

Interest & Impact

Downloads

1 since deposited on 21 Sep 2020
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item